Summary
Acriflavine treatment of Streptomyces aureofaciens gives rise to a high proportion of mutants withloss of antibiotic production and with morphological changes. Mutants so obtained are compared with those arising after UV irradiation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blumauerová, M., Maksimova, T. S., Gause, G. F. and Vanek, Z. (1979). Biotechnology Letters 1, 337 - 341
Hopwood, D. A. (1978). Ann. Rev. Microbiol.32, 373 - 392
Komatsu, K., Leboul, J., Harford, S. and Davies J. (1981). In Microbiology 1981, D. Schlessinger, ed., ASM, Washington D.C. pp 384 - 387
Okanishi, M. (1980). In Molecular Breeding and Genetics of Applied Microorganisms, K. Sakaguchi and M. Okanishi, eds., Academic Press pp 29\2 - 46
Palecková, F., Rehácek, Z. and Hostálek, Z. (1968). Folia Microbiologica (Prague)13, 419 - 423
Zelinková, E., Godány, A., Zelinka, J. (1977). Biologia (Bratislava)32, 223 - 225
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vyskocil, P., Zelený, K. Mutagenic treatment of chlortetracycline producer with acriflavine. Biotechnol Lett 4, 277–280 (1982). https://doi.org/10.1007/BF00132825
Issue Date:
DOI: https://doi.org/10.1007/BF00132825